Long-term outcome of radiation-based conservation therapy for invasive bladder cancer

Urologic Oncology: Seminars and Original Investigations

Volumn 25, Issue 4, 2007, Pages 303-309

  Chung, Peter W M ^a   Bristow, Robert G ^a   Milosevic, Michael F ^a   Yi, Qi long ^a   Jewett, Michael A S ^a   Warde, Padraig R ^a   Catton, Charles N ^a   McLean, Michael ^a   Moore, Malcolm ^a   Tannock, Ian F ^a   Gospodarowicz, Mary K ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Bladder cancer; Bladder conservation; Chemotherapy; Radiotherapy

Indexed keywords

CISPLATIN; DOXORUBICIN; METHOTREXATE; VINBLASTINE;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; BLADDER CANCER; BLADDER WALL; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER SURVIVAL; CARCINOMA IN SITU; CLINICAL TRIAL; CONSERVATIVE TREATMENT; CYSTECTOMY; CYSTOSCOPY; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; MULTIVARIATE ANALYSIS; ORGAN PRESERVATION; OUTCOME ASSESSMENT; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; SURVIVAL TIME; TIME SERIES ANALYSIS; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; CYSTECTOMY; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MUSCLE, SMOOTH; NEOPLASM RECURRENCE, LOCAL; SURVIVAL RATE; TREATMENT OUTCOME; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 34447096867     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urolonc.2006.09.015     Document Type: Article

References (30)

1. Stein J.P., Lieskovsky G., Cote R., et al. Radical cystectomy in the treatment of invasive bladder cancer: Long-term results in 1,054 patients. J Clin Oncol 19 (2001) 666-675
2. Advanced Bladder Cancer Meta-analysis Collaboration. Neoadjuvant chemotherapy in invasive bladder cancer: A systematic review and meta-analysis. Lancet 361 (2003) 1927-1934
3. Hayter C.R., Paszat L.F., Groome P.A., et al. A population-based study of the use and outcome of radical radiotherapy for invasive bladder cancer. Int J Radiat Oncol Biol Phys 45 (1999) 1239-1245
4. Dunst J., Sauer R., Schrott K.M., et al. Organ-sparing treatment of advanced bladder cancer: A 10-year experience. Int J Radiat Oncol Biol Phys 30 (1994) 261-266
5. Kachnic L.A., Kaufman D.S., Heney N.M., et al. Bladder preservation by combined modality therapy for invasive bladder cancer. J Clin Oncol 15 (1997) 1022-1029
6. Shipley W.U. Full-dose irradiation for invasive bladder cancer: Prognostic factors and techniques. Urology 23 (1984) 95-100
7. Greven K.M., Solin L.J., and Hanks G.E. Prognostic factors in patients with bladder carcinoma treated with definitive irradiation. Cancer 65 (1990) 908-912
8. Vale J.A., A'Hern R.P., Liu K., et al. Predicting the outcome of radical radiotherapy for invasive bladder cancer. Eur Urol 24 (1993) 48-51
9. Gospodarowicz M.K., Rider W.D., Keen C.W., et al. Bladder cancer: Long-term follow-up results of patients treated with radical radiation. Clin Oncol (R Coll Radiol) 3 (1991) 155-161
10. Gospodarowicz M.K., Hawkins N.V., Rawlings G.A., et al. Radical radiotherapy for muscle invasive transitional cell carcinoma of the bladder: Failure analysis. J Urol 142 (1989) 1448-1453
11. Fung C.Y., Shipley W.U., Young R.H., et al. Prognostic factors in invasive bladder carcinoma in a prospective trial of preoperative adjuvant chemotherapy and radiotherapy. J Clin Oncol 9 (1991) 1533-1542
12. Quilty P.M., and Duncan W. The influence of hemoglobin level on the regression and long term local control of transitional cell carcinoma of the bladder following photon irradiation. Int J Radiat Oncol Biol Phys 12 (1986) 1735-1742
13. Quilty P.M., Kerr G.R., and Duncan W. Prognostic indices for bladder cancer: An analysis of patients with transitional cell carcinoma of the bladder primarily treated by radical megavoltage X-ray therapy. Radiother Oncol 7 (1986) 311-321
14. Sengelov L., Klintorp S., Havsteen H., et al. Treatment outcome following radiotherapy in elderly patients with bladder cancer. Radiother Oncol 44 (1997) 53-58
15. Fossa S.D., Waehre H., Aass N., et al. Bladder cancer definitive radiation therapy of muscle-invasive bladder cancer. A retrospective analysis of 317 patients. Cancer 72 (1993) 3036-3043
16. Coppin C.M., Gospodarowicz M.K., James K., et al., The National Cancer Institute of Canada Clinical Trials Group. Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. J Clin Oncol 14 (1996) 2901-2907
17. International collaboration of trialists. Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: A randomised controlled trial. Lancet 354 (1999) 533-540
18. Davidson S.E., Symonds R.P., Snee M.P., et al. Assessment of factors influencing the outcome of radiotherapy for bladder cancer. Br J Urol 66 (1990) 288-293
19. Duncan W., and Quilty P.M. The results of a series of 963 patients with transitional cell carcinoma of the urinary bladder primarily treated by radical megavoltage X-ray therapy. Radiother Oncol 7 (1986) 299-310
20. Scrimger R.A., Murtha A.D., Parliament M.B., et al. Muscle-invasive transitional cell carcinoma of the urinary bladder: A population-based study of patterns of care and prognostic factors. Int J Radiat Oncol Biol Phys 51 (2001) 23-30
21. Chahal R., Sundaram S.K., Iddenden R., et al. A study of the morbidity, mortality and long-term survival following radical cystectomy and radical radiotherapy in the treatment of invasive bladder cancer in Yorkshire. Eur Urol 43 (2003) 246-257
22. Zietman A.L., Sacco D., Skowronski U., et al. Organ conservation in invasive bladder cancer by transurethral resection, chemotherapy and radiation: Results of a urodynamic and quality of life study on long-term survivors. J Urol 170 (2003) 1772-1776
23. Rodel C., Grabenbauer G.G., Kuhn R., et al. Combined-modality treatment and selective organ preservation in invasive bladder cancer: Long-term results. J Clin Oncol 20 (2002) 3061-3071
24. Morris M., Eifel P.J., Lu J., et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 340 (1999) 1137-1143
25. Forastiere A.A., Goepfert H., Maor M., et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349 (2003) 2091-2098
26. Cowan R.A., McBain C.A., Ryder W.D., et al. Radiotherapy for muscle-invasive carcinoma of the bladder: Results of a randomized trial comparing conventional whole bladder with dose-escalated partial bladder radiotherapy. Int J Radiat Oncol Biol Phys 59 (2004) 197-207
27. Rozan R., Albuisson E., Donnarieix D., et al. Interstitial iridium-192 for bladder cancer (a multicentric survey: 205 patients). Int J Radiat Oncol Biol Phys 24 (1992) 469-477
28. Van der Steen-Banasik E.M., Visser A.G., Reinders J.G., et al. Saving bladders with brachytherapy: Implantation technique and results. Int J Radiat Oncol Biol Phys 53 (2002) 622-629
29. Poulsen A.L., Horn T., and Steven K. Radical cystectomy: Extending the limits of pelvic lymph node dissection improves survival for patients with bladder cancer confined to the bladder wall. J Urol 160 (1998) 2015-2019
30. Konety B.R., Joslyn S.A., and O'Donnell M.A. Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: Analysis of data from the Surveillance, Epidemiology and End Results Program data base. J Urol 169 (2003) 946-950